Comparison of Ranibizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration treated following a 'Treat and Extend' protocol: efficacy variables from the pre-specified 12-month interim analysis of the RIVAL study

被引：0
|
作者：
Gillies, Mark C. [1 ]
Hunyor, Alex [1 ]
Arnold, Jennifer [2 ]
Pecheur, Francois [3 ]
Underhill, Kathryn [3 ]
Guymer, Robyn H. [4 ]
McAllister, Ian [5 ]
机构：
[1] Univ Sydney, Ophthalmol, Sydney, NSW, Australia
[2] Marsden Eye Specialists, Parramatta, NSW, Australia
[3] Novartis Pharmaceut, Sydney, NSW, Australia
[4] CERA, Sydney, NSW, Australia
[5] Lions Eye Inst, Perth, WA, Australia
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
840
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results
    N Homer
    D S Grewal
    R G Mirza
    A T Lyon
    M K Gill
    Eye, 2015, 29 : 1152 - 1155
  • [32] Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results
    Homer, N.
    Grewal, D. S.
    Mirza, R. G.
    Lyon, A. T.
    Gill, M. K.
    EYE, 2015, 29 (09) : 1152 - 1155
  • [33] TREATMENT PATTERNS OF PATIENTS TREATED WITH RANIBIZUMAB OR AFLIBERCEPT FOR THE MANAGEMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A RETROSPECTIVE COHORT STUDY IN AUSTRALIA
    Ferreira, A.
    Skelly, A.
    Milnes, F.
    VALUE IN HEALTH, 2016, 19 (07) : A574 - A574
  • [34] ENDOPHTHALMITIS FOLLOWING RANIBIZUMAB OR AFLIBERCEPT TREATMENT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD): A RETROSPECTIVE US DATABASE ANALYSIS
    Vote, Brendan
    Dugel, Pravin
    Kelly, Simon P.
    Souied, Eric
    Ferreira, Alberto
    Milnes, Fran
    Clunas, Nathan
    Hashmonay, Ron
    Lu, Jingson
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 : 124 - 124
  • [35] Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen FLUID Study 24-Month Results
    Guymer, Robyn H.
    Markey, Caroline M.
    McAllister, Ian L.
    Gillies, Mark C.
    Hunyor, Alex P.
    Arnold, Jennifer J.
    OPHTHALMOLOGY, 2019, 126 (05) : 723 - 734
  • [36] A 12-month, prospective, observational study of ranibizumab in treatment-naïve Taiwanese patients with neovascular age-related macular degeneration: the RACER study
    Wen-Chuan Wu
    Jiann-Torng Chen
    Ching-Yao Tsai
    Chien-Liang Wu
    Cheng-Kuo Cheng
    Yun-Dun Shen
    Arslan Tsai
    Pei-Chang Wu
    BMC Ophthalmology, 20
  • [37] Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice
    Debourdeau, Eloi
    Beylerian, Helene
    Nguyen, Vuong
    Barthelmes, Daniel
    Gillies, Mark
    Gabrielle, Pierre Henry
    Vujosevic, Stela
    Otoole, Louise
    Puzo, Martin
    Creuzot-Garcher, Catherine
    Wolff, Benjamin
    Daien, Vincent
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (09) : 2343 - 2355
  • [38] Ranibizumab reimbursement and treatment patterns for neovascular age-related macular degeneration in Taiwan- Results from the 12-month, observational RENOWNED study
    Chen, San-Ni
    Lai, Chi-Chun
    Wang, Jia-Kang
    Choi, Hin-Yeung
    Kuo, Chien-Neng
    Tsai, Ching-Yao
    Wang, Hsing-, I
    Yang, Chung-May
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (10) : 2020 - 2027
  • [39] Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degeneration
    Meidong Zhu
    Wijeyanthy Wijeyakumar
    Adil R. Syed
    Nichole Joachim
    Thomas Hong
    Geoffrey K. Broadhead
    Haitao Li
    Kehui Luo
    Andrew Chang
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 : 475 - 484
  • [40] Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degeneration
    Zhu, Meidong
    Wijeyakumar, Wijeyanthy
    Syed, Adil R.
    Joachim, Nichole
    Hong, Thomas
    Broadhead, Geoffrey K.
    Li, Haitao
    Luo, Kehui
    Chang, Andrew
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (03) : 475 - 484
12345